These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 34203237)

  • 101. Resistance to immune checkpoint inhibitors in gastric cancer.
    Liu K; Yuan S; Wang C; Zhu H
    Front Pharmacol; 2023; 14():1285343. PubMed ID: 38026944
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Application of Noninvasive Imaging to Combined Immune Checkpoint Inhibitors for Breast Cancer: Facts and Future.
    Cheng Z; Du Y; Yu L; Yuan Z; Tian J
    Mol Imaging Biol; 2022 Apr; 24(2):264-279. PubMed ID: 35102468
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Multi-Omics Approaches in Immunological Research.
    Chu X; Zhang B; Koeken VACM; Gupta MK; Li Y
    Front Immunol; 2021; 12():668045. PubMed ID: 34177908
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Lessons and Applications of Omics Research in Diabetes Epidemiology.
    Yu G; Tam HCH; Huang C; Shi M; Lim CKP; Chan JCN; Ma RCW
    Curr Diab Rep; 2024 Mar; 24(3):27-44. PubMed ID: 38294727
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Application of omics technologies in cariology research: A critical review with bibliometric analysis.
    Zhang JS; Huang S; Chen Z; Chu CH; Takahashi N; Yu OY
    J Dent; 2024 Feb; 141():104801. PubMed ID: 38097035
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Cancer-on-a-Chip for Modeling Immune Checkpoint Inhibitor and Tumor Interactions.
    Jiang X; Ren L; Tebon P; Wang C; Zhou X; Qu M; Zhu J; Ling H; Zhang S; Xue Y; Wu Q; Bandaru P; Lee J; Kim HJ; Ahadian S; Ashammakhi N; Dokmeci MR; Wu J; Gu Z; Sun W; Khademhosseini A
    Small; 2021 Feb; 17(7):e2004282. PubMed ID: 33502118
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Omics Profiling in Precision Oncology.
    Yu KH; Snyder M
    Mol Cell Proteomics; 2016 Aug; 15(8):2525-36. PubMed ID: 27099341
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Advanced Omics Techniques for Understanding Cochlear Genome, Epigenome, and Transcriptome in Health and Disease.
    Tisi A; Palaniappan S; Maccarrone M
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892216
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Molecular epidemiology of pregnancy using omics data: advances, success stories, and challenges.
    Rahnavard A; Chatterjee R; Wen H; Gaylord C; Mugusi S; Klatt KC; Smith ER
    J Transl Med; 2024 Jan; 22(1):106. PubMed ID: 38279125
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Aging-related biomarker discovery in the era of immune checkpoint inhibitors for cancer patients.
    Al-Danakh A; Safi M; Jian Y; Yang L; Zhu X; Chen Q; Yang K; Wang S; Zhang J; Yang D
    Front Immunol; 2024; 15():1348189. PubMed ID: 38590525
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Knowledge Generation with Rule Induction in Cancer Omics.
    Scala G; Federico A; Fortino V; Greco D; Majello B
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861438
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Spatial omics techniques and data analysis for cancer immunotherapy applications.
    Zhang Y; Lee RY; Tan CW; Guo X; Yim WW; Lim JC; Wee FY; Yang WU; Kharbanda M; Lee JJ; Ngo NT; Leow WQ; Loo LH; Lim TK; Sobota RM; Lau MC; Davis MJ; Yeong J
    Curr Opin Biotechnol; 2024 Jun; 87():103111. PubMed ID: 38520821
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Integrative omics approaches provide biological and clinical insights: examples from mitochondrial diseases.
    Khan S; Ince-Dunn G; Suomalainen A; Elo LL
    J Clin Invest; 2020 Jan; 130(1):20-28. PubMed ID: 31895050
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Omics sciences and precision medicine in sarcoma.
    Bonetti G; Donato K; Dhuli K; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Bernini A; Fulcheri E; Cavalca D; Stuppia L; Stuppia L; Gatta V; Cristoni S; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):68-76. PubMed ID: 37994750
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Single-cell Analysis Technologies for Immuno-oncology Research: from Mechanistic Delineation to Biomarker Discovery.
    Bai Z; Su G; Fan R
    Genomics Proteomics Bioinformatics; 2021 Apr; 19(2):191-207. PubMed ID: 34000441
    [TBL] [Abstract][Full Text] [Related]  

  • 116. The Role of Omics Approaches to Characterize Molecular Mechanisms of Rare Ovarian Cancers: Recent Advances and Future Perspectives.
    Subbannayya Y; Di Fiore R; Urru SAM; Calleja-Agius J
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680597
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Emerging Roles of Single-Cell Multi-Omics in Studying Developmental Temporal Patterning.
    Lopes A; Magrinelli E; Telley L
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050604
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Advance in Multi-omics Research Strategies on Cholesterol Metabolism in Psoriasis.
    Guo Y; Luo L; Zhu J; Li C
    Inflammation; 2024 Jun; 47(3):839-852. PubMed ID: 38244176
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Cardiometabolic health, diet and the gut microbiome: a meta-omics perspective.
    Valles-Colomer M; Menni C; Berry SE; Valdes AM; Spector TD; Segata N
    Nat Med; 2023 Mar; 29(3):551-561. PubMed ID: 36932240
    [TBL] [Abstract][Full Text] [Related]  

  • 120. A comprehensive supportive care program for fine-tuning cancer immunotherapy.
    de Borms AT; Colard-Thomas J; Laurent PI; Coget E; Carbasse C; Annakib S; Thomas QD; Nicolas E; Fiteni F
    Support Care Cancer; 2024 Jun; 32(7):452. PubMed ID: 38907798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.